MktsMarkets

Neumora Therapeutics, Inc.
NASDAQ: NMRAKey statistics
NMRA News
Stories mentioning NMRA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 38,598 | 44,670 | 40,520 | 38,724 | 52,151 | 45,912 | 60,630 | 48,628 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 52,864 | 58,480 | 57,700 | 54,040 | 70,936 | 62,922 | 76,646 | 63,822 |
| Operating Income (Loss) | (52,864) | (58,480) | (57,700) | (54,040) | (70,936) | (62,922) | (76,646) | (63,822) |
| Interest Income | 1,231 | 1,685 | 3,074 | 4,209 | ||||
| Interest Expense | 1,436 | |||||||
| Other Expense | 59.00 | (269.00) | 7.00 | (480.00) | (25.00) | 15.00 | (57.00) | (24.00) |
| Pretax Income | (53,428) | (59,450) | (56,755) | (52,706) | (67,887) | (58,819) | (72,494) | (58,575) |
| Tax Provision | 30.00 | 0.00 | 0.00 | 25.00 | 105.00 | 53.00 | 125.00 | |
| Net Income (Loss) | (53,458) | (59,450) | (56,755) | (52,731) | (67,992) | (58,819) | (72,547) | (58,700) |
| Earnings Per Share (Basic) | (0.30) | (0.36) | (0.35) | (0.33) | (0.42) | (0.37) | (0.45) | (0.37) |
| Earnings Per Share (Diluted) | (0.30) | (0.36) | (0.35) | (0.33) | (0.42) | (0.37) | (0.45) | (0.37) |
| Weighted Average Shares Outstanding (Basic) | 179,872 | 163,391 | 161,838 | 161,691 | 161,451 | 159,377 | 159,576 | 158,984 |
| Weighted Average Shares Outstanding (Diluted) | 179,872 | 163,391 | 161,838 | 161,691 | 161,451 | 159,377 | 159,576 | 158,984 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NMRA
Neumora Therapeutics, Inc. (NASDAQ: NMRA) is a stock listed on the Nasdaq Stock Market under the ticker symbol NMRA. It last traded at $0.3700 (Oct 30, 2026, 4:00 PM ET), down 5.4% on the day. That gives Neumora Therapeutics a market capitalisation of $69.0M.
Over the past 52 weeks NMRA has traded between $0.3200 and $3.65.
For the quarter ended Mar 31, 2026 it reported a net loss of $53.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$53.5M |
| Dec 31, 2025 | — | -$59.5M |
| Sep 30, 2025 | — | -$56.8M |
| Jun 30, 2025 | — | -$52.7M |
From Neumora Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…